Recorlev is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Xeris Pharmaceuticals, Inc.. The primary component is Levoketoconazole.
Product ID | 72065-003_0673111d-f8e9-46d1-b015-a29683c2705e |
NDC | 72065-003 |
Product Type | Human Prescription Drug |
Proprietary Name | Recorlev |
Generic Name | Levoketoconazole |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2021-12-30 |
Marketing Category | NDA / |
Application Number | NDA214133 |
Labeler Name | Xeris Pharmaceuticals, Inc. |
Substance Name | LEVOKETOCONAZOLE |
Active Ingredient Strength | 150 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-12-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RECORLEV 86865505 not registered Live/Pending |
Cortendo AB 2016-01-05 |